Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
1d agoen
From the article
Conditions : Non-Clear Cell Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8 Interventions : Procedure: Biospecimen Collection; Procedure: Bone Scan; Procedure: Computed Tomography; Procedure: Echocardiography Test; Procedure: Magnetic Resonance Imaging; Other: Patient Observation; Biological: Pembrolizumab; Procedure: Positron Emission Tomography Sponsors : National Cancer Institute (NCI) Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Study uses brain's glymphatic system to deliver gene therapy across blood-brain barrier
A new study presents a gene therapy strategy that leverages the brain's glymphatic transport system to deliver engineered adeno-associated v
news-medical.net·27m ago
Blood-brain barrier-like vascular gate identified as key driver of immunotherapy resistance in small cell lung cancer
Researchers have identified a blood-brain barrier-like vascular gate (BVG) in small cell lung cancer (SCLC) and other neuroendocrine cancers
cell.com·4h ago
STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccines
STAT·5h ago
STAT+: White House reviewing top contenders to lead FDA
STAT·7h ago
AI-ECG Models Show Promise for Detecting Structural Heart Disease and Predicting Risk
AI-enabled ECG (AI-ECG) models that detect systolic and diastolic dysfunction can identify patients with structural heart disease (SHD) who
tctmd.com·7h ago
USC Study: AI Therapists Show Strong Communication Skills but Raise Safety Concerns
A USC Viterbi School of Engineering study found that AI large language models (LLMs) show strong performance in general mental health commun
dailycaller.com·8h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.